V Nambiar1, S I Sohn2, M A Almekhlafi3, H W Chang4, S Mishra1, E Qazi1, M Eesa5, A M Demchuk6, M Goyal6, M D Hill7, B K Menon8. 1. From the Calgary Stroke Program, Departments of Clinical Neurosciences (V.N., M.A.A., S.M., E.Q., M.E., A.M.D., M.G., M.D.H., B.K.M.). 2. Departments of Neurology (S.I.S.). 3. From the Calgary Stroke Program, Departments of Clinical Neurosciences (V.N., M.A.A., S.M., E.Q., M.E., A.M.D., M.G., M.D.H., B.K.M.)Department of Internal Medicine (M.A.A.), King Abdulaziz University, Jeddah, Saudi Arabia. 4. Radiology (H.W.C.), Brain Research Institute, Keimyung University, Daegu, South Korea. 5. From the Calgary Stroke Program, Departments of Clinical Neurosciences (V.N., M.A.A., S.M., E.Q., M.E., A.M.D., M.G., M.D.H., B.K.M.)Radiology (M.E., A.M.D., M.G., M.D.H., B.K.M.). 6. From the Calgary Stroke Program, Departments of Clinical Neurosciences (V.N., M.A.A., S.M., E.Q., M.E., A.M.D., M.G., M.D.H., B.K.M.)Radiology (M.E., A.M.D., M.G., M.D.H., B.K.M.)Hotchkiss Brain Institute (A.M.D., M.G., M.D.H., B.K.M.), University of Calgary, Calgary, Alberta, Canada. 7. From the Calgary Stroke Program, Departments of Clinical Neurosciences (V.N., M.A.A., S.M., E.Q., M.E., A.M.D., M.G., M.D.H., B.K.M.)Radiology (M.E., A.M.D., M.G., M.D.H., B.K.M.)Community Health Sciences (M.D.H., B.K.M.), University of Calgary, Calgary, Alberta, CanadaHotchkiss Brain Institute (A.M.D., M.G., M.D.H., B.K.M.), University of Calgary, Calgary, Alberta, Canada. 8. From the Calgary Stroke Program, Departments of Clinical Neurosciences (V.N., M.A.A., S.M., E.Q., M.E., A.M.D., M.G., M.D.H., B.K.M.)Radiology (M.E., A.M.D., M.G., M.D.H., B.K.M.)Community Health Sciences (M.D.H., B.K.M.), University of Calgary, Calgary, Alberta, CanadaHotchkiss Brain Institute (A.M.D., M.G., M.D.H., B.K.M.), University of Calgary, Calgary, Alberta, Canada. docbijoymenon@gmail.com.
Abstract
BACKGROUND AND PURPOSE: Collateral status at baseline is an independent determinant of clinical outcome among patients with acute ischemic stroke. We sought to identify whether the association between recanalization after intra-arterial acute stroke therapy and favorable clinical response is modified by the presence of good collateral flow assessed on baseline CTA. MATERIALS AND METHODS: Data are from the Keimyung Stroke Registry, a prospective cohort study of patients with acute ischemic stroke from Daegu, South Korea. Patients with M1 segment MCA with or without intracranial ICA occlusions on baseline CTA from May 2004 to July 2009 who also had baseline MR imaging were included. Two readers blinded to all clinical information assessed baseline and follow-up imaging. Leptomeningeal collaterals on baseline CTA were assessed by consensus by use of the regional leptomeningeal score. RESULTS: Among 84 patients (mean age, 65.2 ± 13.2 years; median NIHSS score, 14; interquartile range, 8.5), median time from stroke onset to initial MR imaging was 164 minutes. TICI 2b-3 recanalization was achieved in 38.1% of patients and mRS 0-2 at 90 days in 35.8% of patients. In a multivariable model, the interaction between collateral status and recanalization was significant. Only patients with intermediate or good collaterals who recanalized showed a statistically significant association with good clinical outcome (rate ratio = 3.8; 95% CI, 1.2-12.1). Patients with good and intermediate collaterals who did not achieve recanalization and patients with poor collaterals, even if they achieved recanalization, did not do well. CONCLUSIONS: Patients with good or intermediate collaterals on CTA benefit from intra-arterial therapy, whereas patients with poor collaterals do not benefit from treatment.
BACKGROUND AND PURPOSE: Collateral status at baseline is an independent determinant of clinical outcome among patients with acute ischemic stroke. We sought to identify whether the association between recanalization after intra-arterial acute stroke therapy and favorable clinical response is modified by the presence of good collateral flow assessed on baseline CTA. MATERIALS AND METHODS: Data are from the Keimyung Stroke Registry, a prospective cohort study of patients with acute ischemic stroke from Daegu, South Korea. Patients with M1 segment MCA with or without intracranial ICA occlusions on baseline CTA from May 2004 to July 2009 who also had baseline MR imaging were included. Two readers blinded to all clinical information assessed baseline and follow-up imaging. Leptomeningeal collaterals on baseline CTA were assessed by consensus by use of the regional leptomeningeal score. RESULTS: Among 84 patients (mean age, 65.2 ± 13.2 years; median NIHSS score, 14; interquartile range, 8.5), median time from stroke onset to initial MR imaging was 164 minutes. TICI 2b-3 recanalization was achieved in 38.1% of patients and mRS 0-2 at 90 days in 35.8% of patients. In a multivariable model, the interaction between collateral status and recanalization was significant. Only patients with intermediate or good collaterals who recanalized showed a statistically significant association with good clinical outcome (rate ratio = 3.8; 95% CI, 1.2-12.1). Patients with good and intermediate collaterals who did not achieve recanalization and patients with poor collaterals, even if they achieved recanalization, did not do well. CONCLUSIONS:Patients with good or intermediate collaterals on CTA benefit from intra-arterial therapy, whereas patients with poor collaterals do not benefit from treatment.
Authors: Shelagh B Coutts; Michael D Hill; Andrew M Demchuk; Philip A Barber; J H Warwick Pexman; Alastair M Buchan Journal: Stroke Date: 2003-09-11 Impact factor: 7.914
Authors: Simerpreet Bal; Rohit Bhatia; Bijoy K Menon; Nandavar Shobha; Volker Puetz; Imanuel Dzialowski; Jayesh Modi; Mayank Goyal; Michael D Hill; Eric E Smith; Andrew M Demchuk Journal: Int J Stroke Date: 2012-09-13 Impact factor: 5.266
Authors: Matthew B Maas; Michael H Lev; Hakan Ay; Aneesh B Singhal; David M Greer; Wade S Smith; Gordon J Harris; Elkan Halpern; André Kemmling; Walter J Koroshetz; Karen L Furie Journal: Stroke Date: 2009-07-09 Impact factor: 7.914
Authors: Bijoy K Menon; Eric E Smith; Shelagh B Coutts; Donald G Welsh; James E Faber; Mayank Goyal; Michael D Hill; Andrew M Demchuk; Zaheed Damani; Kyung-Hee Cho; Hyuk-Won Chang; Jeong-Ho Hong; Sung Il Sohn Journal: Ann Neurol Date: 2013-09-04 Impact factor: 10.422
Authors: Kevin N Sheth; John B Terry; Raul G Nogueira; Anat Horev; Thanh N Nguyen; Albert K Fong; Dheeraj Gandhi; Shyam Prabhakaran; Dolora Wisco; Brenda A Glenn; Ashis H Tayal; Bryan Ludwig; Muhammad Shazam Hussain; Tudor G Jovin; Paul F Clemmons; Carolyn Cronin; David S Liebeskind; Melissa Tian; Rishi Gupta Journal: J Neurointerv Surg Date: 2012-10-16 Impact factor: 5.836
Authors: Albert J Yoo; Luis A Verduzco; Pamela W Schaefer; Joshua A Hirsch; James D Rabinov; R Gilberto González Journal: Stroke Date: 2009-04-09 Impact factor: 7.914
Authors: A D Horsch; J W Dankbaar; J M Niesten; T van Seeters; I C van der Schaaf; Y van der Graaf; W P Th M Mali; B K Velthuis Journal: AJNR Am J Neuroradiol Date: 2015-04-23 Impact factor: 3.825
Authors: Anna Mm Boers; Ivo Gh Jansen; Olvert A Berkhemer; Albert J Yoo; Hester F Lingsma; Cornelis H Slump; Yvo Bwem Roos; Robert J van Oostenbrugge; Diederik Wj Dippel; Aad van der Lugt; Wim H van Zwam; Henk A Marquering; Charles Blm Majoie Journal: J Cereb Blood Flow Metab Date: 2016-11-19 Impact factor: 6.200
Authors: Clinton D Morgan; Marcus Stephens; Scott L Zuckerman; Magarya S Waitara; Peter J Morone; Michael C Dewan; J Mocco Journal: Interv Neuroradiol Date: 2015-06-10 Impact factor: 1.610
Authors: Juan F Arenillas; Elisa Cortijo; Pablo García-Bermejo; Elad I Levy; Reza Jahan; David Liebeskind; Mayank Goyal; Jeffrey L Saver; Gregory W Albers Journal: J Cereb Blood Flow Metab Date: 2017-11-14 Impact factor: 6.200
Authors: E M Fanou; J Knight; R I Aviv; S-P Hojjat; S P Symons; L Zhang; M Wintermark Journal: AJNR Am J Neuroradiol Date: 2015-10-15 Impact factor: 3.825
Authors: A Z Copelan; E R Smith; G T Drocton; K H Narsinh; D Murph; R S Khangura; Z J Hartley; A A Abla; W P Dillon; C F Dowd; R T Higashida; V V Halbach; S W Hetts; D L Cooke; K Keenan; J Nelson; D Mccoy; M Ciano; M R Amans Journal: AJNR Am J Neuroradiol Date: 2020-11-19 Impact factor: 3.825